Primary Site >> Colorectal Cancer
Gene >> BCL9L
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling. PMID: 17113272 |
Ref: The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells. PMID: 18627596 |
Ref: A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. PMID: 19328798 |
Ref: BCL9-2 promotes early stages of intestinal tumor progression. PMID: 21703997 |
Ref: LEF1 and B9L shield beta-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors. PMID: 24419084 Ref: Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. PMID: 24755471 Ref: Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells. PMID: 24828199 Ref: MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of beta-catenin in human colorectal cancer cells. PMID: 24913975 |
Ref: Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells. PMID: 25712164 Ref: Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels. PMID: 26109429 |
Ref: Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. PMID: 27149842 Ref: The role of Pygo2 for Wnt/ss-catenin signaling activity during intestinal tumor initiation and progression. PMID: 27811361 |
Ref: BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer. PMID: 28073006 |
Ref: Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans. PMID: 30239619 |